Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Jónsson · SciRah

Researcher profile · Semantic Scholar

P. Jónsson

Share profile

P. Jónsson — researcher profile on SciRah

h-index: 17
Works: 55
Citations: 1,036

Most-cited papers

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Shirley V. Wang, S. K. Sreedhara, S. Schneeweiss, J. Franklin +67 more
2022Nature Communications100 citations Open access
Semantic Scholar
Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
A. Makady, A. van Veelen, P. Jónsson, O. Moseley +5 more
2017PharmacoEconomics (Auckland)93 citations Open access
Semantic Scholar
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
L. Orsini, M. Berger, W. Crown, Gregory W. Daniel +12 more
2020Value in Health87 citations Open access
Semantic Scholar
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment
S. Kent, Edward Burn, Dalia Dawoud, P. Jónsson +4 more
2020PharmacoEconomics (Auckland)84 citations Open access
Semantic Scholar
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
J. Pearson-Stuttard, Sara Holloway, R. Polya, R. Sloan +6 more
2022EClinicalMedicine79 citations Open access
Semantic Scholar
Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force.
W. Padula, N. Kreif, D. Vanness, B. Adamson +6 more
2022Value in Health77 citations Open access
Semantic Scholar
The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review
E. Leckenby, Dalia Dawoud, Jacoline C. Bouvy, P. Jónsson
2021Applied Health Economics and Health Policy70 citations Open access
Semantic Scholar
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative
L. Orsini, B. Monz, C. D. Mullins, D. V. Van Brunt +12 more
2020Pharmacoepidemiology and Drug Safety67 citations Open access
Semantic Scholar
Environmental impact assessment in health technology assessment: principles, approaches, and challenges
M. Toolan, Sarah Walpole, K. Shah, J. Kenny +3 more
2023International Journal of Technology Assessment in Health Care53 citations Open access
Semantic Scholar
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance.
A. Jaksa, James Wu, P. Jónsson, H. Eichler +2 more
2021Journal of Comparative Effectiveness Research49 citations Open access
Semantic Scholar
Machine learning and AI research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics and Effectiveness
S. Vollmer, B. Mateen, G. Bohner, F. Király +14 more
2018arXiv.org40 citations
Semantic Scholar
Transferability of real-world data across borders for regulatory and health technology assessment decision-making
A. Jaksa, Patrick J. Arena, Kelvin K. W. Chan, R. Ben-Joseph +2 more
2022Frontiers in Medicine22 citations Open access
Semantic Scholar
The use of nonrandomized evidence to estimate treatment effects in health technology assessment.
S. Kent, Maximilian Salcher-Konrad, S. Boccia, Jacoline C. Bouvy +6 more
2021Journal of Comparative Effectiveness Research22 citations Open access
Semantic Scholar
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
G. Capkun, Sorcha Corry, Oonagh Dowling, Fatemeh Asad Zadeh Vosta Kolaei +7 more
2022International Journal of Technology Assessment in Health Care20 citations Open access
Semantic Scholar
How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
S. Cooper, Jacoline C. Bouvy, Lawrence Baker, F. Maignen +5 more
2020British medical journal18 citations
Semantic Scholar
Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease
M. Dekker, Jacoline C. Bouvy, D. O’Rourke, R. Thompson +3 more
2019Frontiers in Medicine17 citations Open access
Semantic Scholar
Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.
A. Makady, H. Stegenga, A. Ciaglia, Thomas P. A. Debray +8 more
2017Journal of Comparative Effectiveness Research17 citations Open access
Semantic Scholar
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study
A. Jaksa, Liza R. Gibbs, S. Kent, S. Rowark +8 more
2022BMJ Open16 citations Open access
Semantic Scholar
Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate ‘Real World’ Evidence of Comparative Effectiveness and Safety
Shirley V. Wang, Olga V. Patterson, J. Gagne, Jeffrey S. Brown +6 more
2019Drug Safety16 citations Open access
Semantic Scholar
Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life – A Case Study of the Innovative Medicines Initiative
M. Happich, A. Brnabic, D. Faries, K. Abrams +5 more
2020Clinical pharmacology and therapy14 citations Open access
Semantic Scholar
Health Technology Assessment in the Context of Adaptive Pathways for Medicines in Europe: Challenges and Opportunities
Jacoline C. Bouvy, P. Jónsson, Carole Longson, Nick Crabb +1 more
2016Clinical pharmacology and therapy13 citations
Semantic Scholar
Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund.
Tarang Sharma, M. Choudhury, J. C. Rejón-Parrilla, P. Jónsson +1 more
2018BMJ Open9 citations Open access
Semantic Scholar
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework
S. Duffield, P. Jónsson
2023Journal of Comparative Effectiveness Research8 citations Open access
Semantic Scholar
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
David Jenkins, M. Czachorowski, S. Bujkiewicz, P. Dequen +2 more
2014Value in Health7 citations Open access
Semantic Scholar
DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK
J. de Folter, M. Trusheim, P. Jónsson, S. Garner
2018International Journal of Technology Assessment in Health Care6 citations
Semantic Scholar
Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework
Vandana Gupta, Sarah Scott, Mandy Tonkinson, P. Jónsson +2 more
2025Journal of Comparative Effectiveness Research5 citations Open access
Semantic Scholar
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
Jacoline C. Bouvy, P. Jónsson, D. O’Rourke, A. Chadha +7 more
2018CNS Drugs5 citations Open access
Semantic Scholar
Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study
Philani B Mpofu, S. Kent, P. Jónsson, H. Pittell +7 more
2023BMJ Open4 citations Open access
Semantic Scholar
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.
B. King-Kallimanis, M. Calvert, D. Cella, K. Cocks +11 more
2023Value in Health4 citations
Semantic Scholar
A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines
H. Stegenga, M. Chambers, P. Jónsson, R. Thwaites +1 more
20163 citations Open access
Semantic Scholar
Reweighting Rct Evidence To Better Reflect Real Life: A Case Study of The Innovation Medicines Initiative
M. Happich, A. Brnabic, D. Faries, K. Abrams +5 more
20162 citations Open access
Semantic Scholar
Letter in Reply – Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework
V. Ayyar Gupta, Sarah Scott, Mandy Tonkinson, P. Jónsson +2 more
2025Journal of Comparative Effectiveness Research1 citations Open access
Semantic Scholar
PCN170 Can Early U.S. Adoption of Cancer Drugs Inform HTA Decision-Making?
P. Jónsson, P. Mpofu, S. Kent, A. Copeland +5 more
20211 citations Open access
Semantic Scholar
Using Real-World Data (RWD) in Health Technology Assessment (HTA) Practice: A Comparative Study of 5 HTA Agencies
A. Makady, P. V. van Veelen, P. Jónsson, O. Moseley +5 more
20171 citations Open access
Semantic Scholar
Stakeholder Views On The Acceptability Of Real-World Evidence For Informing Trial Design And Assessment Of Relative Effectiveness Of New Medicines.
P. Jónsson, M. Czachorowski, M. Groves, Keith R. Abrams +4 more
2015Value in Health1 citations Open access
Semantic Scholar
Variations in primary care prescribing: lessons to be learnt for GP commissioners
Rachel Houten, A. Wailoo, P. Jónsson, C. McLeod
2013Primary Health Care Research & Development1 citations Open access
Semantic Scholar
EE357 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration and Impacts on Health Care Resource Usage: A Population Based Analysis of Real World Evidence
J. Pearson-Stuttard, S. Holloway, R. Polya, R. Sloan +6 more
2022Value in Health0 citations Open access
Semantic Scholar
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges
J. Kenny, K. Shah, M. Toolan, N. Crabb +4 more
2022International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar
EPH57 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration: A Population Based Analysis of Real World Evidence
J. Pearson-Stuttard, S. Holloway, R. Polya, R. Sloan +6 more
2022Value in Health0 citations Open access
Semantic Scholar
PP07 Improving The Use Of Real-World Evidence In The Development Of NICE Guidance
S. Kent, S. Duffield, S. Rowark, L. Kincaid +3 more
2022International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar
PD23 Assessing The Suitability Of Real-World Data For Answering Decision Problems – NICE’s Data Suitability Assessment Tool
L. Kincaid, V. Ayyar-Gupta, S. Rowark, S. Kent +2 more
2022International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management
S. Rowark, P. Jónsson, S. Kent
2022International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar
PD24 Robust Real-World Evidence Generation In Comparative Effects Studies – NICE’s Methods Guidance
S. Duffield, S. Kent, Manuj Sharma, L. Kincaid +3 more
2022International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar
PGI61 REGULATORY AND HTA ENGAGEMENT IN NEURODEGENERATIVE DISEASE RESEARCH: A DECISION TOOL
D. O’Rourke, K. Harrison, P. Jónsson, Jacoline C. Bouvy
2019Value in Health0 citations Open access
Semantic Scholar
Can we rely on non-randomised studies? Findings from a meta-epidemiological review
J. C. Rejón-Parrilla, Maximilian Salcher-Konrad, M. Nguyen, K. Davis +2 more
2019European Journal of Public Health0 citations Open access
Semantic Scholar
Key enablers and barriers to implementing adaptive pathways in the European setting
J. C. Rejón-Parrilla, P. Jónsson, Jacoline C. Bouvy
2019British Journal of Clinical Pharmacology0 citations Open access
Semantic Scholar
PCV156 A MULTILEVEL ACCESS EVIDENCE FRAMEWORK FOR INNOVATIVE TECHNOLOGIES SPECIFIC TO HAEMATOLOGICAL MALIGNANCIES
K. Harrison, D. O’Rourke, H. Chevrou-séverac, M. Gaudig +6 more
2019Value in Health0 citations Open access
Semantic Scholar
PCP59 - IDENTIFICATION, SELECTION AND MEASUREMENT OF OUTCOMES TO FACILITATE THE USE OF BIG DATA: A TOOLKIT
K. Harrison, H. Stegenga, P. Jónsson
2018Value in Health0 citations Open access
Semantic Scholar
Navigating the use of Real-World Evidence in Effectiveness Research and Patient Access Decisions
R. Thwaites, H. Stegenga, M. Chambers, S. Garner +1 more
2018Value in Health0 citations Open access
Semantic Scholar
OP170 Regulatory And Health Technology Assessment Considerations In Alzheimer's Disease
Jacoline C. Bouvy, P. Jónsson
2018International Journal of Technology Assessment in Health Care0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jacoline C. Bouvy×10
Invite
Jacoline C. Bouvy — researcher profile on SciRah
S. Kent×7
Invite
S. Kent — researcher profile on SciRah
S. Duffield×7
Invite
S. Duffield — researcher profile on SciRah
A. Makady×6
Invite
A. Makady — researcher profile on SciRah

×6

Invite

W. Goettsch — researcher profile on SciRah

Invite

S. Garner — researcher profile on SciRah

Invite

S. Rowark — researcher profile on SciRah

Invite

K. Harrison — researcher profile on SciRah

Shirley V. Wang×4

Invite

Shirley V. Wang — researcher profile on SciRah

D. O’Rourke×4

Invite

D. O’Rourke — researcher profile on SciRah

Invite

H. Stegenga — researcher profile on SciRah

Invite

L. Kincaid — researcher profile on SciRah